期刊文献+

慢性肾脏病患者血浆氨基末端前体脑钠肽与心功能的关系 被引量:2

Relationship of plasma N-terminal pro-brain natriuretic peptide and cardiac function in patients with chronic kidney disease
原文传递
导出
摘要 目的研究血浆氨基末端前体脑钠肽(NT-proBNP)与心功能的关系。方法采用固相免疫层析法检测152例不同分期慢性肾脏病(CKD)组患者与20例对照组血浆NT-proBNP水平,分析其与心脏彩超各指标、生化指标的关系。结果伴有心衰的各期CKD患者NT-proBNP水平远高于同一分期无心衰患者;非心衰组CKD患者的NT-proBNP水平随着肾小球滤过率的下降逐渐升高;NT-proBNP水平与左房内径以及左室舒张末内径、左室收缩末内径均呈正相关,与心脏射血分数呈负相关。结论 NT-proBNP是早期诊断CKD患者无症状性心功能不全的敏感指标。 Objective To study the relationship of plasma N-terminal pro-brain natriuretic peptide(NT-proBNP) and cardiac function in patients with chronic kidney disease(CKD).MethodsPlasma NT-proBNP was examined in 152 CKD patients and 20 healthy subjects.The relationship of plasma NT-proBNP and echocardiographic and biochemistry parameter was analyzed.Results Plasma NT-proBNP level of CKD patients with heart failure was much higher than that of CKD cases in same stage but without heart failure.Plasma NT-proBNP level of CKD patients without heart failure increased with the decrease of the level of estimated glomerular filtration rate(eGFR),which was not in CKD patients with heart failure.NT-proBNP level was positively correlated with left atrial diameter(LAD),left ventricular end-diastolic diameter(LVEDD) and left ventricular end-systolic diameter(LVESD),but negatively correlated with left ventricular ejection frection(LVEF).Conclusion Plasma NT-proBNP is a sensitive marker for diagnosing early symptomless heart failure in CKD patients.
出处 《江苏医药》 CAS CSCD 北大核心 2011年第19期2293-2295,共3页 Jiangsu Medical Journal
关键词 慢性肾脏病 氨基末端前体脑钠肽 心功能 Chronic kidney disease N-terminal pro-brain natriuretic peptide Cardiac function
  • 相关文献

参考文献12

  • 1Sarnak M J, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovaschlar disease[J]. Circulation, 2003,108(17) : 2154-2169.
  • 2Wang AY, Lam CW, Yu CM, et al. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients[J]. J Am Soc Nephrol, 2007,18(1) :321-330.
  • 3Hobbs RE, Mills RM. Endogenous B-type natriuretic peptide:a limb of the regulatory response to acutely deeompensated heart failure[J]. Clin Cardiol, 2008,31 (9) : 407-412.
  • 4Almirez R, Protter AA. Clearance of human brain natriuretic peptide in rabbits: effect of the kidney, the natriuretic peptide clearance receptor, and peptidase activity [J]. J Pharmacol Exp Ther, 1999,289 (2) : 976-980.
  • 5Vickery S, Price CP, John RI, et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy [J]. Am J Kidney Dis,2005,46(4):610-620.
  • 6Defiippi CR, Fink JC, Nass CM, et al. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis[J]. Am J Kidney Dis, 2005,46 (1) : 35-44.
  • 7Liang F,O'Rear J,Schellenberger U, et al. Evidence for functional heterogeneity of circulating B-type natriuretic peptide [J]. J Am Coll Cardiol, 2007,49 (10) : 1071-1078.
  • 8周文彦,倪兆慧,顾乐怡,方炜,王琴,牟姗,曹励欧,俞赞喆,钱家麒.慢性肾脏病非透析患者脑钠素与肾功能及左室肥厚的关系[J].中华医学杂志,2007,87(46):3284-3287. 被引量:4
  • 9Khan IA, Fink J, Nass C, et al. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients[J]. Am J Cardiol, 2006,97(10) : 1530-1534.
  • 10Nakatani T, Naganuma T, Masuda C, et al. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis[J]. Int J Mol Med, 2002, 10 (4) : 457-461.

二级参考文献20

  • 1赵雪燕,杨跃进,张健,党爱民,倪新海,黄洁,康晟,马卫华,赵冬云.B型利钠肽在诊断左心衰竭中的价值[J].中华医学杂志,2006,86(17):1165-1169. 被引量:97
  • 2M Kaisar, N Isbel, DW Johnson. Cardiovascular disease in patients with chronic kidney disease. A clinical review. Minerva Urol Nefrol, 2007,59:281-297.
  • 3Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998, 32:s112-s119.
  • 4Bianchi ME, Farias EF, Bolano J, et al. Epidemiology of renal and cardiovascular risk factors in Toba Aborigines. Ren Fail, 2006, 28:665-670.
  • 5H Dokainish, WA Zoghbi, NM Lakkis, et al. Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure. J Am Coll Cardiol,2004,93 : 1130 - 1135.
  • 6Koglin J, Pehlivanli S, Schwaiblamir M, et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol, 2001,38:1934-1941.
  • 7Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2005,67:2089-2100.
  • 8Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation, 1977,55:613-618.
  • 9Robert NF, Patrick S, Parfrey, et al. Cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998, 32: s112-s119.
  • 10Adeera L, Ognjenka K, Brendan B, et al. Cardiovascular disease in patients with chronic kidney disease : geting to the heart of the matter. Am J Kidney Dis, 2001, 38:1398-1407.

共引文献3

同被引文献20

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部